Connecticut Medical Marijuana Law

Status

Operational

Law Signed:

2012

QUALIFYING CONDITIONS

Amyotrophic lateral sclerosis
Autism spectrum disorder
Cachexia
Cancer
Cerebral palsy
Chronic neuropathic pain associated with degenerative spinal disorders
Chronic pain of at least 6 months duration associated with a specified underlying chronic condition refractory to other treatment intervention
Chronic pancreatitis (subject to approval by the legislature’s Regulations Review Committee)
Complex regional pain syndrome
Crohn’s disease
Cystic fibrosis
Ehlers-Danlos syndrome
Epilepsy
Female orgasmic difficulty/disorder
Glaucoma
Hydrocephalus with intractable headache
HIV or AIDS
Huntington’s disease and/or related movement disorders
Interstitial cystitis
Intractable headache syndromes
Intractable neuropathic pain that is unresponsive to standard medical treatments
Intractable spasticity
Irreversible spinal cord injury with objective neurological indication of intractable spasticity
Medial arcuate ligament syndrome, or MALS syndrome
Multiple sclerosis
Muscular dystrophy
Neuropathic facial pain
Osteogenesis imperfecta
Parkinson’s disease
Post herpetic neuralgia
Post-surgical back pain with a condition called chronic radiculopathy
Post laminectomy syndrome
Post-traumatic stress disorder (PTSD)
Severe psoriasis and psoriatic arthritis
Severe rheumatoid arthritis
Sickle cell disease
Spasticity
Spasticity or neuropathic pain associated with fibromyalgia
Terminal illness requiring end-of-life care
Tourette syndrome
Ulcerative colitis
Uncontrolled intractable seizure disorder
Vulvodynia and vulvar burning
Wasting syndrome
Other medical conditions may be approved by the Department of Consumer Protection